iSONEP to Treat Persistent Pigment Epithelial Detachment (PED) in Subjects With Exudative Age-Related Macular Degeneration (AMD) or Polypoidal Choroidal Vasculopathy (PCV)

This study has been terminated.

( Sponsor decision; not safety related )

Study NCT01334255 Information provided by Lpath, Inc.

First Received on April 8, 2011. Last Updated on April 22, 2013 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Additional conditions recognized in this trial

More general conditions related to this trial

Interventions listed in this trial

Sponsors listed in this trial

Lpath, Inc.
Pfizer